Post by Genentech
943,449 followers
We’re proud to share that the FDA has accepted our application for a combination treatment for people living with large B-cell lymphoma, an aggressive form of blood cancer. Because this disease progresses quickly, patients need timely access to effective care. This combination could expand access to care and bring treatment closer to home for patients. Learn more: http://spr.ly/6040BDOJ94
Video Content